Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022
依拉环素治疗前四年：2018年至2022年美国5个地区19家医院的健康结果和耐受性数据
期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.02351-23
Kunz Coyne, Ashlan J; Alosaimy, Sara; Lucas, Kristen; Lagnf, Abdalhamid M; Morrisette, Taylor; Molina, Kyle C; DeKerlegand, Alaina; Schrack, Melanie Rae; Kang-Birken, S Lena; Hobbs, Athena L V; Agee, Jazmin; Perkins, Nicholson B 3rd; Biagi, Mark; Pierce, Michael; Truong, James; Andrade, Justin; Bouchard, Jeannette; Gore, Tristan; King, Madeline A; Pullinger, Benjamin M; Claeys, Kimberly C; Herbin, Shelbye; Cosimi, Reese; Tart, Serina; Veve, Michael P; Jones, Bruce M; Rojas, Leonor M; Feehan, Amy K; Scipione, Marco R; Zhao, Jing J; Witucki, Paige; Rybak, Michael J
